z-logo
Premium
Dysfunction of coronary smooth muscle Ca 2+ regulation in the progression of metabolic syndrome and coronary artery disease in Ossabaw miniature swine
Author(s) -
McKenney Mikaela Lee,
Kohr Meredith C,
Alloosh Mouhamad,
Schultz Kyle A,
Bell Lauren N,
Tune Johnathan D,
Sturek Michael
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.26.1_supplement.866.17
Subject(s) - medicine , coronary artery disease , metabolic syndrome , endocrinology , basal (medicine) , caffeine , calcium , cardiology , extracellular , chemistry , diabetes mellitus , obesity , biochemistry
Coronary smooth muscle (CSM) cell Ca 2+ regulation was studied in the Ossabaw swine model of metabolic syndrome (MetS) and coronary artery disease (CAD). MetS was induced by excess calorie atherogenic diet for 9 or 12 months and compared to lean controls on normal diet. Isometric tension studies on isolated coronary arteries revealed that 9 months of MetS increased tension development to KCl depolarization vs. lean controls, whereas 12 months reduced tension vs. control. MetS increases CAD and CSM Ca 2+ dysregulation. CSM were isolated enzymatically and digitally imaged with the fluorescent Ca 2+ indicator fura‐2. There was no difference in basal Ca 2+ levels between groups. We released sarcoplasmic reticulum (SR) Ca 2+ stores with caffeine. The peak Ca 2+ release was increased in 9 month and decreased in 12 month MetS vs. lean. This Ca 2+ response largely represents the caffeine‐sensitive SR Ca 2+ store capacity. After the SR store depletion, a sustained Ca2+ signal above basal levels remained in the 9 month MetS group, reflecting store‐operated Ca 2+ entry and decreased Ca 2+ extrusion ability. Intravascular ultrasound and micro‐computed tomography imaging showed greater atherosclerosis and extracellular calcification in 12 vs. 9 month MetS. Collectively, these data suggest that CSM undergo dedifferentiation from a contractile to an osteogenic phenotype with progressively increasing CAD. (NIH HL062552 , HL092245 )

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom